A subscription to JoVE is required to view this content. Sign in or start your free trial.
Not Published
This manuscript describes a simple method for the formulation and control of vaccines with a water-in-oil-in-water adjuvant at the laboratory scale, compatible with the safety requirements of live recombinant vaccines.
Adjuvants play an important role to enhance the efficacy of vaccines and are often required to direct immune responses toward specific long-term protection. Several vaccination trials have described promising results with the combination of recombinant adenoviruses and water-in-oil-in-water (W/O/W) adjuvants. Specifically, the antibody response elicited by vaccines based on canine adenovirus type 2 (CAV2) vectors steadily increases after being formulated in a W/O/W emulsion. Thus, the production process directly impacts its physical properties, which are crucial to obtain stable, safe, and efficient vaccine emulsions. This article describes a lab-scale process for the formulation of O-206, a W/O/W adjuvant, in a total volume of 1 mL and 10 mL, that is compatible with safety requirements of live vaccines based on recombinant adenovirus. Moreover, this article provides reliable and simple quality control analyses of the W/O/W vaccine emulsion formulated with recombinant adenoviruses.
In the context of growing populations, secure access to uncontaminated food while improving animal and human health will become increasingly important. The expression "One World, One Health" describes a multidisciplinary international cooperation associating animal and human health to notably better prevent and control zoonotic agents1. Indeed, 60% of emerging infectious diseases in humans are transmitted by animals2.
Nowadays, vaccination is still the most effective way to prevent and control infectious diseases in humans and animals. In comparison, only drinking water allows such a r....
1. Emulsification process of 1 mL formulation for rodents
Typical results obtained from the appearance test are shown in Figure 1. An emulsion is stable if there is no default or non-critical defaults. A default is considered non-critical when the difference of both color and phase is low. Non-critical defaults are hand reversible because the properties of the emulsion are conserved (e.g., whitish phase at the surface). A default is considered critical when the physical properties of the emulsion are permanently altered: when there is a change in d.......
The protocol in this study details two lab-scale processes adapted to the safety requirements of live vaccines based on recombinant adenoviruses formulated with W/O/W adjuvant.
These optimized protocols allow a robust and reproducible formulation. However, it is crucial to scrupulously respect certain critical steps. Firstly, it is important to obtain a final adjuvant/aqueous phase ratio of 50/50 weight/weight. Secondly, warming of the oil and aqueous phases before their assembly must ensure a.......
Manon Broutin was funded by a CIFRE PhD fellowship (2017/1080) from the French Association Nationale de la Recherche et de la Technologie (ANRT) in the framework of a public-private partnership between Ecole Nationale Vétérinaire d'Alfort and SEPPIC, part of Air Liquid Healthcare.
....Name | Company | Catalog Number | Comments |
15 mL conical tube | FALCON | 352096 | |
20 mL dispersing tube | IKA | 3700600 | Tube with rotor-stator element. Sterile model, with pierceable membrane |
50 mL dispersing tube | IKA | 3701600 | Tube with rotor-stator element. Sterile model, with pierceable membrane |
DMEM (1x) + GlutaMAX-I | GIBCO | 61965-026 | |
Fetal Calf Serum | EUROBIO | CVFSVF00-01 | |
Homogenizer | IKA | 3646000 | |
Laser diffraction particle size analyzer | Malvern Panalytical | Mastersizer 3000 | |
MDCK (NBL-2) | ATCC | CCL-34 | |
Microtube 2 mL | EPPENDORF | 30120094 | |
O-201 | SEPPIC | MONTANIDE ISA 201 VG | |
O-206 | SEPPIC | MONTANIDE ISA 206 VG | |
Penicillin (10,000 U/mL) Streptomycin (10,000 µg/mL) | GIBCO | 15140-212 | |
Pipette Tips C POSD 1000 µL S 180/3 | RAININ | 17008609 | 100 μL – 1000 μL |
Positive-Displacement Pipette MR-1000 | RAININ | 17008580 | 100 μL – 1000 μL |
Sodium Chloride 0.9% injectable | BBRAUN | ||
Sodium pyruvate 100 mM (100x) | GIBCO | 11360-039 | |
Sterile glass vial | WEST PHARMACEUTICAL SERVICES | 8072035 | Optional |
Syringe 1 mL | BBRAUN | 9166017V | Syringe without rubber |
Syringe 10 mL | BBRAUN | 4606728V | Syringe without rubber |
Syringe 2 mL | BBRAUN | 4606701V | Syringe without rubber |
Syringe 5 mL | BBRAUN | 4606710V | Syringe without rubber |
Vial adapter | WEST PHARMACEUTICAL SERVICES | 8072035 | Optional |
Vortex mixer | SCIENTIFIC INDUSTRIES | SI-0256 | Vortex-Genie 2 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved